MONTREAL, August 9, 2021 – Today, CanVECTOR launched its 2021 Pilot Trials Funding Competition with a submission deadline of Monday, October 4, 2021. The purpose of this funding opportunity is to build research capacity related to VTE and to enable CanVECTOR scientists to collect pilot data that will inform the conduct of larger multicentre clinical trials and increase the ability to attract external peer-reviewed funding.
A total of $100,000 is available to fund one or more pilot studies between January 2022 and December 2023. Funding for individual projects may be awarded over one or two years. It is expected that the applicants will seek peer-reviewed funding for the full trial within 3 years of receiving CanVECTOR funds.
Since the inception of the competition, the Network has awarded eight studies with pilot trial funding. For more information on past winners, visit the Clinical Trials & Shared Platforms platform page of the website.
Quick Facts
- A total of $100,000 is available to fund one or more pilot studies.
- The project is expected to collect pilot data at two or more sites to inform a randomized controlled trial (RCT) that will be conducted at multiple CanVECTOR sites.
- The research focus is to be related to prevention, diagnosis, or treatment of venous thromboembolism or its sequelae.
- The project team for the pilot study will include an investigator triad (senior investigator, an early or mid-career investigator, and a thrombosis fellow or trainee). It is also expected that the team will include a methods expert and a patient partner (or patient engagement strategy).
- At least one of the investigators in the triad must be a CanVECTOR member.
Key Dates
- October 4, 2021: Application submission deadline (submit to info@canvector.ca)
- Mid-December 2021: Announcement of funding decision.
Competition Details
Contact
For more information, please contact Nicole Langlois – Network Manager of Clinical Research, Ottawa Office, by email: info@canvector.ca